AIM ImmunoTech, Inc. (AIM)

1.37 -0.08 (-5.52%) USD  |  NYAM  |  Dec 12, 16:00
1.36 -0.01 (-0.73%) After-Hours: 20:00
More

AIM ImmunoTech EPS Diluted (TTM): -14.94 for Sept. 30, 2025

EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for AIM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Agenus, Inc. -2.128
Curis, Inc. -3.677
Halozyme Therapeutics, Inc. 4.757
Protalix Biotherapeutics, Inc. 0.0695
Armata Pharmaceuticals, Inc. -1.323